Is CORT stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
On Friday 21st of November 2014, Corcept Therapeutics had a stock price of $2.99. If you invested back then, your return now would be a profit of $53.10 per share or 1 775.92%
Yes, the average daily trading liquidity for Corcept Therapeutics is $39.49 million. You should therefore be able to get in and out of your positions relatively fast.
Corcept Therapeutics has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 334.85, the company's ability to pay off the debt is good. Corcept Therapeutics has a very good net profit margin of 22.48% and should have very high tolerances against inflation.
We have calculated the inflation risk for Corcept Therapeutics to be low [0 out of 1]